Natera price target raised to $185 from $150 at BTIG

BTIG raised the firm’s price target on Natera (NTRA) to $185 from $150 and keeps a Buy rating on the shares. The company’s Q3 results “knocked it out of the park again” as its fundamentals keep improving, the analyst tells investors in a research note. BTIG adds that Natera is reinvesting its operating cash flow into the business, fortifying its leadership position in sales, marketing, medical affairs and on the legal front.